Views & Analysis | Perspectives on pharma industry issues

Patients

Older couple high five each other on bicycles at top of hill

The strategic opportunity: Owning the behaviour layer

Behaviour is the layer that lifestyle, physical performance, and nutrition – together – occupy.

Sales & Marketing

Media Partner

Why BIO-Europe 2026 matters: The evolution of strategic biop...

2026 marks a significant evolution for BIO-Europe.

Digital

AI is redefining decision-making in biopharma R&D

AI has kickstarted a new wave of innovation in biopharma R&D.

Patients

pharmaphorum podcast Episode 273, James Davis, PA Consulting

Deliver prevention at scale, PA Consulting’s James Davis

James Davis, a healthcare expert at PA Consulting, discusses the digital foundations needed to unlock a prevention first NHS.

R&D

two healthcare professionals looking at chart

Sponsored

Decentralisation by design: Bringing the trial closer withou...

In the third episode of the IQVIA-sponsored PSCS leadership video series, Sinead Callinan, Head of Patient Centred Delivery, discusses DCTs.

Digital

Doctor connecting continuous glucose monitor with smartphone

Digital innovation and the Direct-To-Patient Model

Innovation is of no worth if it doesn’t provide better outcomes for patients. Indeed, such advancements should hold as centre the amelioration of the overall patient experience.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Digital

HCP holding tablet with AI visual applied

Sponsored

Decoding physician prescribing behaviour: A data-driven jour...

Identifying high-volume prescribers and engaging with key opinion leaders (KOLs) in a target therapeutic area can be a challenge.

Digital

Advancing Precision Care For All

Precision medicine is oft spoken about these days, as it is finally addressing the elephant in the room: one size – or, more appropriately, one dose – does not fit all.

Sales & Marketing

Media Partner

Why BIO-Europe 2026 matters: The evolution of strategic biop...

2026 marks a significant evolution for BIO-Europe.

Sales & Marketing

Recruitment concept graphic on beige background

Changing Faces: Agency, consultancy, and investor hires, Jun...

Agencies, consultancies, investment groups, and wider services firms saw significant talent movement across June and July.

Digital

AI is redefining decision-making in biopharma R&D

AI has kickstarted a new wave of innovation in biopharma R&D.

Digital

Sponsored

Technology solutions for smarter clinical trials: Inventus

In an exclusive video interview, Steve Sanghera – CEO and co-founder of Inventus – sat down with pharmaphorum to discuss the company's journey & ethos

Market Access

What India can learn from Kinvard Bio

India needs its own version of pull, designed for an Indian payer mix, an Indian procurement structure, and an Indian distributor network.

Market Access

The new commercialisation playbook: What BIO 2026 taught eme...

BIO International focused on how emerging biotech companies should approach their first product launch outside the United States, typically in Europe.